Lexicon Pharmaceuticals, Inc.

NASDAQ:LXRX

Biotechnology

Healthcare
$1.72 -2.64%

-$0.05 today

Market cap
$765.80M
Beta
1.07
P/E (TTM)
-30.5
EPS (TTM)
-$0.07
52W Low $0.71High $2.53

Volume 2.02M

Average 2.48M

Price history

Lexicon Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+17.01%

Period high

$2.64

Period low

$1.14

Latest

$1.72

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 9, 2026Nov 9, 2026
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
SC 13G/ANov 5, 2026Nov 5, 2026
EFFECTAug 14, 2026Aug 17, 2026
10-QAug 6, 2026Aug 6, 2026
SC 13G/AAug 6, 2026Aug 6, 2026
8-KAug 6, 2026Aug 6, 2026
S-8Aug 6, 2026Aug 6, 2026
S-3Aug 6, 2026Aug 6, 2026
4Jun 4, 2026Jun 4, 2026
4Jun 4, 2026Jun 4, 2026
4Jun 4, 2026Jun 4, 2026
4Jun 4, 2026Jun 4, 2026
4Jun 4, 2026Jun 4, 2026

Competitors

Who does Lexicon Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about LXRX's filings, answered from its disclosures.

What is the latest LXRX filing?

The latest filing shown is 4 dated Nov 9, 2026.

How many recent filings does LXRX have?

Intrinsic Alpha currently shows 20 recent filings for LXRX.